Certified by Founder Lodge
ImpriMed, Inc.
United States - Mountain View, California
START UP
1 Disclosed Funding Rounds $23,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed’s key product, Personalized Prediction Profile, has been used by board-cer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 20 ,2023 | Series A | $23,000,000 |
Murex Partners
KDB Silicon Valley LLC
Ignite Innovation
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Pryzm | $2,000,000 | (Aug 29, 2024)
Ancilia Biosciences | $4,200,000 | (Aug 29, 2024)
Melodi Health | $10,750,000 | (Aug 29, 2024)
Parry Labs | $80,000,000 | (Aug 29, 2024)
Agency | $2,600,000 | (Aug 29, 2024)
